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Introduction
Cancer, a term applied to a group of different diseases can 
be generally described as an uncontrolled multiplication 
of cells at any part of the body. These abnormal cells 
can create expansive masses, spread to vital organs and 
eventually cause patient death (1). Cytotoxic compounds 
are the majority of drugs currently used for cancer 
chemotherapy. The first step of developing new antitumor 
compounds is testing a wide range of compounds both 
natural and synthetic with the aim of discovering molecules 
of useful properties. Plant kingdom provides a rich and 
wonderful source of biologically active compounds. There 
are about 250 000-500 000 plant species on earth, out of 
which only about 20% have been submitted to biological 
and phytochemical screening. Besides, plant species 
investigated for anticancer potentials are also a very small 
fraction (2,3). So, a huge number of plant species still 
remain to be studied and described in terms of biological 
and phytochemical profiles.
Cousinia, one of the largest genera of Asteraceae, with 600-
Seyed Ebrahim Sajjadi1, Mustafa Ghanadian2,1*, Mehrangiz Haghighi1, Leili Mouhebat3
1Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan,  Iran
3Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan,  Iran
Implication for health policy/practice/research/medical education:
In the present study, we evaluated the cytotoxicity properties of Cousinia verbascifolia fractions on cancer cells of ovarian and colon 
cancer cells. Moderated toxicity of fractions indicated that this plant has the value of more phytochemical consideration to found 
anti-cancer lead compounds and generating new achievements in medicinal chemistry.
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Introduction: Little information is available about phytochemical and biological properties of 
Cousinia genus. In a primary study, seven Cousinia species including C. verbascifolia showed 
cytotoxic activity ranged between 18.4 ± 0.59 to 87.9 ± 0.58 μg/mL. To the best of our knowledge, 
no other biological studies have been conducted on this plant. Therefore, in this study the cytotoxic 
effect of Cousinia verbascifolia Bunge against OVCAR-3 and HT-29 cancer cells was evaluated.
Methods: Filtration and in vacuo concentration of methanol extract resulted in a green gum which 
was subjected on reverse column chromatography. Semi polar fraction (41.3 g) eluted with water: 
methanol (20:80), was then subjected on a silica gel column chromatography using hexane/acetone 
and resulted in 11 fractions. Finally, cytotoxic activities against ovarian and colon cancer cells 
were determined at a wavelength of 570 nm by Matrix metalloproteinase protein (MTT) standard 
method. 
Results: None of the fractions showed highly cytotoxic activity. Based on NCI, fractions Fr. 1, 
Fr. 2, Fr. 4, Fr. 5, Fr. 6, Fr. 8 and Fr. 10 showed moderately cytotoxicity with IC50 values ranged 
between 119 to 190 μg/mL against OVCAR-3 cells. Fractions Fr. 1, Fr. 2, Fr. 6, Fr. 7 and Fr. 8 showed 
moderately cytotoxic activity ranged between 118 to 194 μg/mL against HT-29 cells. Fr. 10 and Fr. 
11 showed no cytotoxic activity. 
Conclusion: Due to the inhibitory properties of extract and its fractions on cancer cells, 
identification of responsible compounds possessing cytotoxic effects for generating possible new 
approach in medicinal chemistry are recommended. 
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700 species, is one of the most diverse genera in central 
and south west Asia. About 250 species of the genus 
are distributed throughout Iran, comprising About 200 
endemic species (4-7). Cousinia verbascifolia Bunge, is a 
monocarpic biennial plant, up to 45 cm high, stems simple 
or branched from the base, leaves lyrate with spiny-dentate 
margin, flowers 50-150; corolla pink, rose or purple, 20-
35 mm long. The flowering period of the plant is May to 
July. This plant is endemic to Kopetdagh (NE Iran and S 
Turkmenistan), open areas, scrublands and stony slopes 
(6). Little information is available about its phytochemical 
and biological properties. Phytochemical studies on some 
Cousinia species provide some information about their 
chemical constituents including: acetylenes, triterpenes, 
steroids, sesquiterpene lactones, and flavonoids (8-17). In a 
previous study, the cytotoxic activity against Fibrosarcoma 
WEHI 164 cancer cells, as well as antibacterial and Matrix 
metalloproteinase protein (MMP) inhibitory effects of a 
total ethanol extract of seven Cousinia species including 
C. verbascifolia were tested (18). In this study total extract 
of these plants showed cytotoxic activity with IC50 values 
ranged between 18.4 ± 0.59 to 87.9 ± 0.58 μg/mL. 
To the best of our knowledge, no other biological studies 
have been conducted on this plant. Therefore, in this study 
the cytotoxic effect of Cousinia verbascifolia Bunge against 
OVCAR-3 and HT-29 cancer cells was evaluated.
Materials and methods
Plant material
Flowering aerial parts of C. verbascifolia from Asteracea 
family were collected from Salehabad, Torbate-Jam, 
Khorassan-Razavi province, Iran in May 2013 and 
authenticated by Dr. Iraj Mehregan. A voucher specimen 
(No. 2838) was deposited at the Herbarium unit of the 
Pharmacognosy Department, School of Pharmacy, 
Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Extraction and fractionation
Aerial parts of plant material (3.5 kg) were air-dried in 
the shade and reduced to fine particles using an electric 
mill. The powdered plant was extracted exhaustively via 
percolation using methanol as solvent at a flow rate of 4 
ml/min for 10 days. The extract was concentrated under 
reduced pressure by a rotary evaporator at a temperature 
not exceeding 50°C. The concentrated extract (450 g) 
was mixed with appropriate amount of Celite, left to dry, 
sieved to obtain fine homo sized particles. It was subjected 
to Medium Pressure Liquid Chromatography (MPLC) 
on C-18 column and water: methanol (0→100) as mobile 
phase. Aqueous fraction eluted with water: methanol 
(70:30) containing polar contents and fraction eluted by 
methanol (100%) containing fats and chlorophyll were 
excluded from the study. Semi-polar fraction (41.3 g) 
eluted with water: methanol (20:80), was subjected on a 
silica gel column chromatography (400 g silica gel, 7×30 
cm) using hexane/acetone (97:3) as mobile phase with 
increasing acetone to 100%. 
MTT viability assay
Human ovarian carcinoma cancer cell line OVCAR-3, and 
colon carcinoma cancer cell line HT-29 were obtained 
from Pasteur Institute of Iran. The cell lines were grown 
in RPMI-1640 media supplemented with 10% fetal calf 
serum, 100 U/ml + 100 µg/ml penicillin and streptomycin 
at 37°C in 5% CO2 condition. Cell viability was determined 
by colorimetric assay, using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) and compared 
with untreated controls. Cells were seeded at 5 × 103 cells/
well in 96-well plates. After incubation, compounds at 
concentrations of 5, 50, and 500 µg/ml were added and 
incubated again for 48 h. Then, MTT (5 mg/ml in PBS) 
was added to each well and the cells were incubated for 
4 hours. The supernatants were aspirated and 200 μl of 
dimethyl sulfoxide was added to each well. The plates were 
shaken for 10 minutes and using colorimetric method, the 
absorbance was read by the microplate reader (Bio-Rad, 
Hercules, CA, USA) at 570 nm (19). 
Average absorbances of triplicate treated cellsCell viability = ×100
Average absorbances of controlcells
The criteria used to categorize the cytotoxicity of C. 
verbascifolia fractions against OVCAR-3 and HT-29, 
based on U.S. National Cancer Institute (NCI) and Geran 
protocol was as follows: IC50 ≤ 20 µg/ml = highly cytotoxic, 
IC50 ranged between 21 and 200 µg/ml = moderately 
cytotoxic, IC50 ranged between 201 and 500 µg/ml = weakly 
cytotoxic and IC50 > 501 µg/ml = no cytotoxicity (20-23).
Statistical analysis
All samples were presented as mean ± SD for three 
measurements. Unpaired Student’s t test was used to 
calculate P<0.05 for each compound against the control 
(+ve). The dose-response curves were plotted to enable 
the calculation of IC50 for each sample.
Results 
Semi-polar fraction obtained from MPLC was subjected 
to silica-gel column chromatography (CC) and eluted 
with n-hexane: acetone with increasing polarity. Isolated 
fractions were organized by TLC profile into 11 combined 
fractions (Fr. 1-Fr. 11). The fractions were concentrated 
by a rotary evaporator at 40°C and stored in refrigerator at 
-20°C before running biological assays (Table 1). 
To investigate the cytotoxic effects of different factions of 
the C. verbascifolia, on the cell viability, OVCAR-3 and 
HT-29 cell lines were incubated with the concentrations 
of 5, 50, and 500 μg/mL of fractions 1-11. None of the 
fractions showed significant cytotoxic effect (P<0.05) 
at concentrations of 5, and 50 µg/ml against OVCAR-3 
cell line. Fr. 1-Fr. 10 showed significant cytotoxic effect 
at concentration of 500 µg/ml against OVCAR-3 cell 
lines (P<0.05). Fractions 1-11 inhibited growth of HT-
29 cells in a concentration-dependent manner. Fr. 1, Fr. 
2 and Fr. 4-Fr. 11 showed significant cytotoxic effect at 
concentration of 50 and 500 µg/ml against HT-29 cell 
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lines (P<0.05). Cytotoxicity activities of Fr. 1-11 against 
cancer cell lines: OVCAR-3 and HT-29 cells are displayed 
in Figure 1.
A fitted dose-response curve was plotted to enable the 
calculation of the concentrations that could kill 50% of the 
cells (IC50). The IC50 was calculated for all of the fractions 
with cytotoxic activities (Table 2). The cytotoxicity data 
based on IC50 values are displayed in Table 2.
A fitted dose-response curve were plotted to enable the 
calculation of the concentrations that kill 50% of the cells 
(IC50). The criteria used were as follows: IC50<20 µg/ml 
(high cytotoxic activity), IC50: 20-100 µg/ml (moderate 
cytotoxic activity), IC50: 201-500 µg/ml (weak cytotoxic 
activity), IC50>500 µg/ml (no cytotoxic activity).
Discussion
Fr. 1-Fr. 10 inhibited growth of OVCAR-3 and HT-29 
cells in a concentration-dependent manner. None of the 
fractions showed high cytotoxic activity. Fractions Fr. 1, 
Fr. 2, Fr. 4, Fr. 5, Fr. 6, Fr. 8 and Fr. 10 showed moderate 
cytotoxic activity against OVCAR-3 cells according to 
a criteria based on NCI and Geran protocols (22,23). 
Figure 1. Cytotoxic effect of different fractions: F1-F11 of C. 
verbascifolia against ovarian OVCAR-3 (a) and colon HT-29 (b) 
cancer cell lines. Cells were treated with different concentrations 
of fractions 1-11 for 48 hours, and Cytotoxicity was assessed by 
MTT assay. Results (mean ± SD) were calculated as percent of 
corresponding control values. ٭P<0.05, ٭٭P<0.001 are significant. 
Statistical analysis was performed by unpaired Student’s t test.
Table 1. Solvent system employed for column chromatography
Combined Fraction n-hexane: acetone
Fr. 1 93:7
Fr. 2 88:12
Fr. 3 80:20
Fr. 4 80:20
Fr. 5 70:30
Fr. 6 50:50
Fr. 7 50:50
Fr. 8 50:50
Fr. 9 0:100
Fr. 10 0:100
Fr. 11 Methanol (100%)
Table 2. IC50 Values of C. verbascifolia fractions against ovarian (OVCAR-3) and colon (HT-29) cancer cell lines
OVCAR-3 HT-29
Fraction IC50 ± SD (μg/mL) Cytotoxic activity IC50 ± SD (μg/mL) Cytotoxic activity
Fr. 1 162.73±11.9 Moderate 125.4±8.3 Moderate
Fr. 2 138.68±0.84 Moderate 73.4±8.4 Moderate
Fr. 3 221.3±0.35 Weak 370.2±24.8 Weak
Fr. 4 119.92±12.15 Moderate 214.8.5±20.8 Weak
Fr. 5 149.26±10.61 Moderate 481.6±45.3 Weak
Fr. 6 190.09±63.64 Moderate 162.5±18.2 Moderate
Fr. 7 232.08±15.87 Weak 118±11.2 Moderate
Fr. 8 121.46±18.38 Moderate 194.6±15.2 Moderate
Fr. 9 289.52±28.78 Weak 392.3±38.9 Weak
Fr. 10 171±16.06 Moderate >500 No
Fr. 11 >500 No >500 No
A fitted dose-response curve were plotted to enable the calculation of the concentrations that kill 50% of the cells (IC50). The criteria used were 
as follows: IC50<20 µg/ml (high cytotoxic activity), IC50: 20-100 µg/ml (moderate cytotoxic activity), IC50: 201-500 µg/ml (weak cytotoxic activity), 
IC50>500 µg/ml (no cytotoxic activity).
Fractions Fr. 1, Fr. 2, Fr. 6, Fr. 7 and Fr. 8 showed moderate 
cytotoxic activity against HT-29 cells. The highest 
cytotoxic activities were observed for Fr. 4, and Fr. 8, with 
IC50 values of 120-121 μg/mL against OVCAR-3 and for 
Fr. 2 with IC50 values of 73.4 μg/mL against HT-29 colon 
cancer cells. The lowest cytotoxic effects were observed 
for Fr.10 against HT-29 and Fr. 11 against both cell lines 
with IC50 values more than 500 μg/mL. 
Despite the large body of work on taxonomy, systematics, 
and phylogeny studies of Cousinia species, their biological 
and phytochemical studies are very limited. Based on 
previous studies, some species of Cousinia including C. 
verbascifolia as reported by Shahverdi et al., have shown 
cytotoxic, MMP inhibitory and antbacterial activities (18). 
In this study ethanol extract of C. verbascifolia exhibited 
high cytotoxic effect against fibrosarcoma cell line (WEHI 
Sajjadi SE et al.
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164) with IC50 value of 18.4 ± 0.59. In contrast, the ethanol 
extract of C. shulabadensis, exhibited weak cytotoxicity 
with IC50 value of 304.5 ± 0.61 μg/mL. 
Comparatively, among the plants from the group 
“Arctium-Cousinia complex”; Arctium, the closely related 
genus to Cousinia (6), has showed considarable cytotoxic 
activity against cancer cell lines. Recently, arctigenin, a 
lignane-9,9’-olide structure isolated from Arctium lappa, 
showed tumor specific cytotoxicity against lung, liver and 
stomach cancer cells (23).
Phytochemical assessments in Cousinia species revealed 
the presence of sesquiterpene lactones (SLs) mainly 
guaianolides and oxygenated bisabolene derivatives, 
and flavonoids (11-13,18). SLs possess a wide range of 
biological activities including cycotoxic, and antitumor 
effects (9,10). So, the cytotoxic properties observed in C. 
verbascifolia less polar fractions like Fr. 2 and Fr. 4 could be 
contributed to the presence of SLs. Cytotoxic activities of 
semi polar fractions like Fr. 8 might be due to the presence 
of flavonoids, lignanes or other phenolic compounds. Fr. 
10 and Fr. 11 as polar fractions showed no cytotoxicities. 
Conclusion
Due to the inhibitory properties of extract and its 
fractions on cancer cells, identification of responsible 
compounds possessing cytotoxic effects for generating 
possible new approach in medicinal chemistry are 
recommended. 
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